Drug intelligence / Profile preview

cetirizine + pseudoephedrine

Development stage
Unknown
Lead developer
UCB
Modality
Small Molecules
Administration
Oral
01

Overview

Cetirizine + pseudoephedrine is a fixed-dose combination of two small molecule drugs: cetirizine, a second-generation antihistamine, and pseudoephedrine, a sympathomimetic decongestant. This oral medication is used to treat symptoms associated with seasonal or perennial allergic rhinitis, such as nasal congestion, sneezing, runny nose, itching of the nose or throat, and watery eyes. Cetirizine works by selectively antagonizing peripheral histamine H1 receptor to block the effects of histamine released during allergic reactions. Pseudoephedrine acts as an agonist at adrenergic receptors in the nasal mucosa to constrict blood vessels and reduce swelling and congestion. The combination provides both antihistaminic relief for allergy symptoms and decongestant action for nasal stuffiness[1][3][4][5][8].

Brand names
Zyrtec-DAll Day Allergy-DGoodsense Cetirizine D-12 HourKS Aller-Tec D-12Wal-Zyr DAller-Tec DCetiri-DCirrus
Other names
cetirizine and pseudoephedrine
02

Targets

ADRA1 (Alpha-1 adrenergic receptor family)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on cetirizine + pseudoephedrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cetirizine + pseudoephedrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call